Seeking a post-doctoral research position in biochemistry or molecular biology
Dr Sujeeve Jeganathan completed his PhD in Biochemistry (University of Ottawa, Ottawa, Ontario, Canada) and a short-term postdoctoral fellowship (PDF) in Neurogenetics (Massachusetts General Hospital / Harvard Medical School, Boston, Ma., USA). His PhD thesis was on the regulation of phospholipid signaling and actin cytoskeletal remodeling by the eukaryotic protein translation elongation factor eEF1A2. His postdoctoral work was on the identification of kinases involved in NF2-mediated mTOR regulation through kinome screens.
Dr Jeganathan has expertise in a wide range of cellular and molecular biology techniques including DNA, RNA and protein handling, various in vitro cell assays (drug cytotoxicity, cell proliferation, adhesion, apoptosis and anoikis), gene and protein knockdown studies, immunofluorescence microscopy (deconvolution and confocal), protein-protein interaction and enzyme kinetics assays, lipid kinase assays, and mutagenesis studies. He has also worked with mouse models of breast and ovarian cancer.
Dr Jeganathan has a passion for signaling pathways and their role in cancer initiation, progression and regression. He is particularly interested in looking at how nutrition (herbs and botanicals) can be used to fight cancer. He is also interested in identifying novel targets and how they contribute to disease, and developing and validating drugs / inhibitors to these proteins. If you might have a research opportunity, please contact Dr Jeganathan directly via .
To obtain a copy of Dr Jeganathan’s CV, please contact .
Seeking a research position in cancer genetics or molecular biology
Dr Anubha Saxena completed a PhD on the molecular genetics of breast cancer at JMI, India and is currently working as a postdoctoral fellow at the Brain and Mind Research Institute (University of Sydney). Her current work is on RNA interference of BACE1 in Alzheimer's disease.
Dr Saxena has five years research experience having worked on breast cancer methylation, polymorphism and gene expression analysis; and molecular studies of drug resistance in Leishmania and the detection of cytomegalovirus in human test samples using ELISA and nested PCR.
Dr Saxena has expertise in a range of techniques and methodologies including DNA, RNA, protein handling, plasmid isolation, PCR, Western Blot, ELISA, cloning and immunohistochemistry. In addition to research, Dr Saxena has worked as a part-time lecturer (undergraduate and postgraduate) at JMI University.
Dr Saxena would like to continue to pursue a career in cancer research. If you might have a research opportunity, please contact Dr Saxena directly via .
To obtain a copy of Dr Saxena’s resume, please contact Merilyn Heuschkel via .
Seeking a PhD opportunity in chemistry
Rasmani Hazra completed a BSc (Hons) in Chemistry and Masters in Biochemistry at the University of Kalyani in India. She is currently working as a Research Assistant at the Western Australian Institute for Medical Research. In 2010, Rasmani is moving to Sydney and is hoping to commence a PhD in chemistry.
If you might have an opportunity for Rasmani please contact her directly via .
If you would like a copy of Rasmani’s resume please contact .
Seeking cancer cell lines
Professor Kate Jolliffe, a synthetic chemist at the University of Sydney, has recently synthesised a natural product reported to be active against human bronchopulmonary non small cell lung carcinoma line (NSCLC-N6). Kate and her colleagues would like to test the cytotoxicity of the synthetic material against this cell line (by MTT assay) but they are having trouble finding a source of these cells.
If you might be able to provide Kate with this source, please contact her directly on 02 9351 2297 or at
Seeking a postdoctoral position investigating candidate genes for human diseases
Alesia Ivashkevich received a Master of Science in Radiobiology from the University College of London, UK, and completed a PhD in Radiation Biology at the Institute of Pathology at the Helmholtz Centre in Munich, Germany. She has also worked for one year as a Research Officer at the St Vincent’s Institute in Melbourne.
Alesia’s has previously been involved in a number of projects including the study of the accumulation of mitochondrial mutations after irradiation/with age, immunohistological characterization of the eyeless (EYL) mouse and finding the mutation in the Pitx3 gene (the publication is submitted), and investigation of radiosensitivity of LEC rats at the cellular level and the analysis of candidate genes. At the St Vincent’s Institute she studied the function of a novel protein in DNA repair pathways in terms of phosphorylation and foci formation.
She has a strong background in pathways of DNA repair, cell cycle and cancer, as well as the identification of genes involved in human pathological conditions.
Alesia is currently looking for a postdoctoral position in Sydney, and is particularly interested in the investigation of candidate genes for human diseases and in characterization of their function, regulation, and involvement in signalling pathways.
If you might have an opportunity for Alesia please contact her directly via .
If you would like a copy of Alesia’s resume please contact .
Seeking clinical collaborators in breast cancer research
Dr Alistair McEwan is a new lecturer in the Faculty of Engineering at the University of Sydney. He has worked on a new medical imaging technology at University College London and Philips, Germany. The technology is Impedance Tomography which induces insensible electrical currents into the body and produces an image of the impedance distribution. While it can not compete with MRI or CT on spatial resolution (the images are rather like FMRI or PET) it can be extremely portable (our current device is the size of an ipod) and uses no ioniszing radiation. These features make it attractive for GP offices, front line screening applications where a positive reading would be followed up by traditional imaging.
Dr McEwan believes that he has a good opportunity at the University of Sydney to trial an improved device with the expertise of Professor Hans Coster in Chemical Engineering and after discussions with him he is looking for clinical contacts in breast cancer screening, surgery or oncology who would be interested in being involved in trialling the device.
Having spent the last 6 years working with clinicians, Dr McEwan realises they are extremely busy with very limited time to entertain new research methods, however he would be able to offer support and in the first instance are looking for clinical guidance and advice with the thinking to apply for a grant to hire a technician to run some field trials. Perhaps there are other research projects already running that Dr McEwan and Professor Hans Coster could join?
If you might be interested in collaborating with Dr McEwan, please contact him directly via or on 02 9351 7256.
If you have any items to add to the Cancer Research Network website, please email details to the .